Rx drug information, pharmaceutical research, clinical trials, news, and more
Effect of renal impairment on the pharmacokinetics, efficacy, and safety of albiglutide. [2014]
Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus. [2009]
Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing. [2009]
Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes. [2008]
GLP-1R agonist therapy for diabetes: benefits and potential risks. [2013]
Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis. [2012]
Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults. [2012]
All Rights reserved - Copyright DrugLib.com, 2006-2017